A US investment firm is suing the Canadian government for alleged unfulfilled agreements related to the demise of a new wireless competitor, say reports.
US-based Quadrangle Group is suing Industry Canada for $1.2 billion in damages, accusing the federal group of neglecting to fulfill an agreement to have wireless spectrum transferred from failed start-up Mobilicity to one of the five major carriers after five years.
Industry giant Telus has reportedly offered to acquire Mobilicity. The company is currently running under court protection.
Industry Canada has reportedly refused to allow Mobilicity to transfer spectrum to Telus, however.
According to the lawsuit, Quadtrangle argues that Industry Canada assured financial backers of Mobilicity that the new company could boost competition in the market and that investments were secure because Mobilicity spectrum licenses could eventually be sold to larger rivals.
The plaintiffs, Quadrangle and Data & Audio-Visual Enterprises Investments, reportedly invested a combined $243 million to the Canadian government for Mobilicity to acquire its spectrum in 2008.
The establishment of Mobilicity was intended to boost competition in the wireless industry as Canada looks to lower consumer costs. The market is largely controlled by Telus, Rogers and Bell; together, they control 90 percent of the industry.
Mobilicity has made little impact on the three giants, reports say.
Industry Canada says the claims are unfounded.
Full content: City News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas